|
Bravo-Perez C, Serna MJ, Esteban J, Fernandez-Mellid E, Fontanes-Trabazo E, Lorenzo A, Calvino-Suarez M, Minano A, Padilla J, Roldan V, Vicente V, Corral J, de la Morena-Barrio ME. Anticoagulant therapy in patients with congenital FXI deficiency. Blood Adv. 2021 Oct 26;5(20):4083-4086. doi: 10.1182/bloodadvances.2021005695. PubMed PMID: 34597376; PubMed Central PMCID: PMC8945614.
AÑO: 2021; IF: 7.637
|
34597376
|
Ding WY, Rivera-Caravaca JM, Marin F, Torp-Pedersen C, Roldan V, Lip GYH. Prediction of Residual Stroke Risk in Anticoagulated Patients with Atrial Fibrillation: mCARS. J Clin Med. 2021 Jul 29;10(15):3357. doi: 10.3390/jcm10153357. PubMed PMID: 34362143; PubMed Central PMCID: PMC8348193.
AÑO: 2021; IF: 4.964
|
|
Proietti M, Esteve-Pastor MA, Rivera-Caravaca JM, Roldan V, Roldan Rabadan I, Muniz J, Cequier A, Bertomeu-Martinez V, Badimon L, Anguita M, Lip GYH, Marin F; FANTASIIA Study Investigators. Relationship between multimorbidity and outcomes in atrial fibrillation. Exp Gerontol. 2021 Oct 1;153:111482. doi: 10.1016/j.exger.2021.111482. Epub 2021 Jul 23. PubMed PMID: 34303775.
AÑO: 2021; IF: 4.253
|
|
Rivera-Caravaca JM, Ding WY, Marin F, Roldan V, Lip GYH; Christina J.-Y. Lee MD, PhD; Christian Torp-Pedersen MD, DMSc. Prediction of ischemic stroke in different populations: a comparison of absolute stroke risk and CHA2DS2-VASc in real-world and clinical trial patients. Eur J Intern Med. 2022 Apr;98:122-124. doi: 10.1016/j.ejim.2021.12.014. Epub 2021 Dec 21. No abstract available. PubMed PMID: 34952769.
AÑO: 2022; IF: 8.0
|
|
Sanchez-Fuentes A, Rivera-Caravaca JM, Lopez-Galvez R, Marin F, Roldan V. Non-vitamin K Antagonist Oral Anticoagulants and Drug-Food Interactions: Implications for Clinical Practice and Potential Role of Probiotics and Prebiotics. Front Cardiovasc Med. 2022 Jan 17;8:787235. doi: 10.3389/fcvm.2021.787235. eCollection 2021. PubMed PMID: 35111826; PubMed Central PMCID: PMC8801490.
AÑO: 2021; IF: 5.846
|